These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34293488)

  • 1. Next-Generation Sequencing-Based Antigen-Receptor Gene Clonality Assays: Will They Become the Clinical Standard?
    Ho C; Rothberg PG
    J Mol Diagn; 2021 Sep; 23(9):1043-1046. PubMed ID: 34293488
    [No Abstract]   [Full Text] [Related]  

  • 2. Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study.
    Brüggemann M; Kotrová M; Knecht H; Bartram J; Boudjogrha M; Bystry V; Fazio G; Froňková E; Giraud M; Grioni A; Hancock J; Herrmann D; Jiménez C; Krejci A; Moppett J; Reigl T; Salson M; Scheijen B; Schwarz M; Songia S; Svaton M; van Dongen JJM; Villarese P; Wakeman S; Wright G; Cazzaniga G; Davi F; García-Sanz R; Gonzalez D; Groenen PJTA; Hummel M; Macintyre EA; Stamatopoulos K; Pott C; Trka J; Darzentas N; Langerak AW;
    Leukemia; 2019 Sep; 33(9):2241-2253. PubMed ID: 31243313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell clonality assessment: past, present and future.
    Mahe E; Pugh T; Kamel-Reid S
    J Clin Pathol; 2018 Mar; 71(3):195-200. PubMed ID: 29055897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Good laboratory practice for clinical next-generation sequencing informatics pipelines.
    Gargis AS; Kalman L; Bick DP; da Silva C; Dimmock DP; Funke BH; Gowrisankar S; Hegde MR; Kulkarni S; Mason CE; Nagarajan R; Voelkerding KV; Worthey EA; Aziz N; Barnes J; Bennett SF; Bisht H; Church DM; Dimitrova Z; Gargis SR; Hafez N; Hambuch T; Hyland FC; Luna RA; MacCannell D; Mann T; McCluskey MR; McDaniel TK; Ganova-Raeva LM; Rehm HL; Reid J; Campo DS; Resnick RB; Ridge PG; Salit ML; Skums P; Wong LJ; Zehnbauer BA; Zook JM; Lubin IM
    Nat Biotechnol; 2015 Jul; 33(7):689-93. PubMed ID: 26154004
    [No Abstract]   [Full Text] [Related]  

  • 5. CloneRetriever: An Automated Algorithm to Identify Clonal B and T Cell Gene Rearrangements by Next-Generation Sequencing for the Diagnosis of Lymphoid Malignancies.
    Halper-Stromberg E; McCall CM; Haley LM; Lin MT; Vogt S; Gocke CD; Eshleman JR; Stevens W; Martinson NA; Epeldegui M; Holdhoff M; Bettegowda C; Glantz MJ; Ambinder RF; Xian RR
    Clin Chem; 2021 Nov; 67(11):1524-1533. PubMed ID: 34491318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in clinical next-generation sequencing: target enrichment and sequencing technologies.
    Ballester LY; Luthra R; Kanagal-Shamanna R; Singh RR
    Expert Rev Mol Diagn; 2016; 16(3):357-72. PubMed ID: 26680590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Identification of immunoglobulin and T-cell receptor gene rearrangements--prerequisite for monitoring of minimal residual disease in Polish acute lymphoblastic leukemia patients based on European standards. Preliminary results].
    Dawidowska M; Derwich K; Szczepański T; Jółkowska J; Witt M; Wachowiak J
    Med Wieku Rozwoj; 2006; 10(1 Pt 2):323-34. PubMed ID: 17028396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition affecting RQ-PCR-based assessment of minimal residual disease in acute lymphoblastic leukemia: reversal by addition of bovine serum albumin.
    Moppett J; van der Velden VH; Wijkhuijs AJ; Hancock J; van Dongen JJ; Goulden N
    Leukemia; 2003 Jan; 17(1):268-70. PubMed ID: 12529693
    [No Abstract]   [Full Text] [Related]  

  • 9. [Towards a national standardisation of NGS studies in the diagnosis of myopathies].
    Krahn M; Cerino M; Campana-Salort E; Cossée M
    Med Sci (Paris); 2017 Nov; 33 Hors série n°1():30-33. PubMed ID: 29139383
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical investigational studies for validation of a next-generation sequencing in vitro diagnostic device for cystic fibrosis testing.
    Grosu DS; Hague L; Chelliserry M; Kruglyak KM; Lenta R; Klotzle B; San J; Goldstein WM; Moturi S; Devers P; Woolworth J; Peters E; Elashoff B; Stoerker J; Wolff DJ; Friedman KJ; Highsmith WE; Lin E; Ong FS
    Expert Rev Mol Diagn; 2014 Jun; 14(5):605-22. PubMed ID: 24844137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A competitive PCR-based method using TCRD, TCRG and IGH rearrangements for rapid detection of patients with high levels of minimal residual disease in acute lymphoblastic leukemia.
    Guidal C; Vilmer E; Grandchamp B; Cavé H
    Leukemia; 2002 Apr; 16(4):762-4. PubMed ID: 11960365
    [No Abstract]   [Full Text] [Related]  

  • 12. ClonoSEQ assay for the detection of lymphoid malignancies.
    Monter A; Nomdedéu JF
    Expert Rev Mol Diagn; 2019 Jul; 19(7):571-578. PubMed ID: 31179776
    [No Abstract]   [Full Text] [Related]  

  • 13. A new case of acute lymphoblastic leukemia B-cell type with chromosomal rearrangements involving the T-cell receptor breakpoint at band 14q11.
    Cigudosa JC; Calasanz MJ; Gullón A; Prósper F; Cuesta B; Rifón J; Rocha E
    Am J Hematol; 1992 Oct; 41(2):137-9. PubMed ID: 1415175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considerations for monitoring minimal residual disease using immunoglobulin clonality in patients with precursor B-cell lymphoblastic leukemia.
    Jo I; Chung NG; Lee S; Kwon A; Kim J; Choi H; Jang W; Kim S; Lee JW; Yoon JH; Cho B; Han K; Kim Y; Kim M
    Clin Chim Acta; 2019 Jan; 488():81-89. PubMed ID: 30389459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell receptor gene rearrangements and the diagnosis of human T-cell neoplasms.
    Cossman J; Uppenkamp M; Andrade R; Medeiros LJ
    Crit Rev Oncol Hematol; 1990; 10(3):267-81. PubMed ID: 2257088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936.
    Evans PA; Pott Ch; Groenen PJ; Salles G; Davi F; Berger F; Garcia JF; van Krieken JH; Pals S; Kluin P; Schuuring E; Spaargaren M; Boone E; González D; Martinez B; Villuendas R; Gameiro P; Diss TC; Mills K; Morgan GJ; Carter GI; Milner BJ; Pearson D; Hummel M; Jung W; Ott M; Canioni D; Beldjord K; Bastard C; Delfau-Larue MH; van Dongen JJ; Molina TJ; Cabeçadas J
    Leukemia; 2007 Feb; 21(2):207-14. PubMed ID: 17170731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell Neoplasms.
    Arcila ME; Yu W; Syed M; Kim H; Maciag L; Yao J; Ho C; Petrova K; Moung C; Salazar P; Rijo I; Baldi T; Zehir A; Landgren O; Park J; Roshal M; Dogan A; Nafa K
    J Mol Diagn; 2019 Mar; 21(2):330-342. PubMed ID: 30590126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision Medicine Requires Precision Laboratories.
    Rajeevan MS; Li T; Unger ER
    J Mol Diagn; 2017 Mar; 19(2):226-229. PubMed ID: 28130021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-Generation Sequencing-Based Clonality Assessment of Ig Gene Rearrangements: A Multicenter Validation Study by EuroClonality-NGS.
    van den Brand M; Rijntjes J; Möbs M; Steinhilber J; van der Klift MY; Heezen KC; Kroeze LI; Reigl T; Porc J; Darzentas N; Luijks JACW; Scheijen B; Davi F; ElDaly H; Liu H; Anagnostopoulos I; Hummel M; Fend F; Langerak AW; Groenen PJTA;
    J Mol Diagn; 2021 Sep; 23(9):1105-1115. PubMed ID: 34186174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGH.
    Wu D; Emerson RO; Sherwood A; Loh ML; Angiolillo A; Howie B; Vogt J; Rieder M; Kirsch I; Carlson C; Williamson D; Wood BL; Robins H
    Clin Cancer Res; 2014 Sep; 20(17):4540-8. PubMed ID: 24970842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.